The possible effect of anti-diabetic agents GLP-1RA and SGLT-2i on the respiratory system function.
抗糖尿病藥物 GLP-1RA 和 SGLT-2i 對呼吸系統功能的可能影響。
Endocrine 2024-09-17
Novel antihyperglycaemic drugs and prevention of chronic obstructive pulmonary disease exacerbations among patients with type 2 diabetes: population based cohort study.
新型降血糖藥物及預防慢性阻塞性肺疾病惡化在2型糖尿病患者中的應用:人口基礎的cohort研究。
BMJ 2022-11-07
Association of adverse respiratory events with sodium-glucose cotransporter 2 inhibitors versus dipeptidyl peptidase 4 inhibitors among patients with type 2 diabetes in South Korea: a nationwide cohort study.
韓國2型糖尿病患者中鈉葡萄糖共同轉運蛋白2抑制劑與二肽基胺肽酶4抑制劑相比,不良呼吸事件的關聯性:全國性群體研究。
BMC Med 2023-02-22
The Role of Glucagon-Like Peptide-1 Receptor Agonists in Chronic Obstructive Pulmonary Disease.
GLP-1 受體激動劑在慢性阻塞性肺疾病中的作用。
Int J Chron Obstruct Pulmon Dis 2023-06-28
The relationship between the use of GLP-1 receptor agonists and the incidence of respiratory illness: a meta-analysis of randomized controlled trials.
GLP-1 受體激動劑使用與呼吸道疾病發生率之關係:隨機對照試驗的荟萃分析。
Diabetol Metab Syndr 2023-07-28
Association of GLP-1 Receptor Agonists with Chronic Obstructive Pulmonary Disease Exacerbations among Patients with Type 2 Diabetes.
GLP-1 受體激動劑與慢性阻塞性肺疾病惡化在 2 型糖尿病患者中的關聯。
Am J Respir Crit Care Med 2024-02-17
Protective Effects of Home T2DM Treatment with Glucagon-Like Peptide-1 Receptor Agonists and Sodium-Glucose Co-transporter-2 Inhibitors Against Intensive Care Unit Admission and Mortality in the Acute Phase of the COVID-19 Pandemic: A Retrospective Observational Study in Italy.
在COVID-19大流行的急性階段,家庭T2DM治療中GLP-1受體激動劑和SGLT-2抑製劑對於減少重症監護病房入院和死亡的保護效應:意大利的一項回顧性觀察研究。
Diabetes Ther 2024-04-22
Relationship between Glucagon-like Peptide-1 Receptor Agonists and Cardiovascular Disease in Chronic Respiratory Disease and Diabetes.
GLP-1受體激動劑與慢性呼吸道疾病和糖尿病心血管疾病的關係。
Biomedicines 2024-03-30
The Association between GLP-1 Receptor-Based Agonists and the Incidence of Asthma in Patients with Type 2 Diabetes and/or Obesity: A Meta-Analysis.
GLP-1受體激動劑與第二型糖尿病和/或肥胖患者哮喘發生率之間的關聯:一項荟萃分析。
Biomed Environ Sci 2024-07-11
The role of Sodium-Glucose Transporter-2 Inhibitors (SGLT-2i) in preventing chronic obstructive disease exacerbation in patients with diabetes and COPD: An electronic health database analysis.
鈉-葡萄糖轉運蛋白-2 抑制劑 (SGLT-2i) 在預防糖尿病和慢性阻塞性肺病 (COPD) 患者慢性阻塞性疾病惡化中的作用:電子健康數據庫分析。
Heart Lung 2024-07-19
Effect of anti-diabetic agent on interstitial lung disease in patients with diabetes mellitus.
抗糖尿病藥物對糖尿病患者間質性肺病的影響。
Naunyn Schmiedebergs Arch Pharmacol 2024-07-20